Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)

China flag China · Delayed Price · Currency is CNY
58.36
+1.45 (2.55%)
At close: Mar 27, 2026
Market Cap15.46B +72.1%
Revenue (ttm)1.60B +18.3%
Net Income154.09M +36.0%
EPS0.58 +34.9%
Shares Out264.98M
PE Ratio100.62
Forward PE52.81
Dividendn/a
Ex-Dividend Daten/a
Volume7,249,723
Average Volume6,689,221
Open56.30
Previous Close56.91
Day's Range56.10 - 58.73
52-Week Range26.61 - 90.68
Beta-0.40
RSI50.97
Earnings DateMar 25, 2026

About SHE:300049

Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. The company operates in two segments: pharmaceutical production and sales; and diagnostic equipment R&D, production and sales. The pharmaceutical production and sales segment produces and sells products, such as Fufang Biejiaruangan tablets and shell fat capsules. The diagnostic equipment R&D, production and sales segment develops, produces, and sells the FibroScan series of liver fibrosis diagnostic instrument... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 867
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300049
Full Company Profile

Financial Performance

In 2025, SHE:300049's revenue was 1.60 billion, an increase of 18.26% compared to the previous year's 1.35 billion. Earnings were 154.09 million, an increase of 36.02%.

Financial Statements